JAMA Network Open Corrects Affiliation Record in Immunotherapy Trial Article
A correction has been issued for the Original Investigation Large Language Models and Adverse Event Detection Within Immunotherapy Clinical Trials, after the journal identified incomplete author affiliation information for Julian C. Hong, MD, MS. The amended record adds two institutional ties: the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, and Weill Cancer Hub West, Stanford University – University of California, San Francisco.
The change is administrative rather than scientific, but it still matters in a field where authorship metadata carries real weight. In oncology research, institutional affiliation helps readers place expertise, interpret potential collaboration networks, and trace where a study was conceived, supported, and clinically grounded. A missing affiliation can obscure the role of a cancer center or academic partnership that contributed to the work, especially when the paper sits at the intersection of oncology, informatics, and trial safety surveillance.
This correction leaves the article’s scientific content unchanged. The study title itself points to a high-stakes application: using large language models to detect adverse events within immunotherapy clinical trials. Even when no efficacy or safety data are altered, the accuracy of the author record remains part of the scientific archive. Readers depend on those details to understand academic responsibility, institutional representation, and the provenance of the work.
One sentence captures the entire scope of the correction: the affiliation list was incomplete. The journal has now amended that record.
Why Affiliation Accuracy Matters in Oncology Informatics
In modern clinical publishing, affiliation data are not decorative. They identify the centers where investigators are embedded, and in a paper focused on adverse event detection, that context can help readers assess the clinical environment behind the research question. A comprehensive cancer center affiliation suggests close proximity to oncology practice, trial conduct, and the day-to-day realities of treatment toxicity monitoring. A research network such as Weill Cancer Hub West signals an added layer of cross-institution collaboration, which is often central to data-driven cancer science.
For studies involving artificial intelligence, the institutional footprint is especially relevant. Large language model research in medicine depends on clinical language, chart abstraction, trial documentation, and specialist interpretation. Those ingredients usually emerge from teams that straddle cancer care, academic informatics, and translational research. The correction does not change any analytic claim about model performance, but it does restore a more complete account of where the work was anchored.
Authorship corrections also carry publication ethics implications. Journals maintain a permanent scientific record, and even small errors can ripple through citation databases, institutional reporting systems, and author profiles. A missed affiliation can affect how a researcher’s contributions are indexed and how institutions document participation in collaborative science. In practical terms, precise metadata supports both accountability and discoverability.
The Scientific Article Remains Intact
The original investigation remains the same article it was before the correction: a study of adverse event detection within immunotherapy clinical trials using large language models. No endpoint, cohort detail, performance metric, or clinical conclusion was changed in the notice. The correction addresses the author line only, which means readers should not interpret it as a revision of the underlying data or results.
That distinction matters in academic medicine. A correction to affiliations is not a retraction, a data amendment, or a reinterpretation of findings. It is a formal update to the bibliographic record, designed to keep the published article aligned with the investigators and institutions actually involved. For readers who rely on journal archives to follow the evolution of a research program, these amendments preserve the integrity of the publication trail.
A Small Correction With Institutional Consequences
In oncology publishing, institutional attribution has consequences beyond the journal page. It affects how cancer centers document scholarship, how collaborative hubs demonstrate output, and how academic partnerships are represented in the literature. When a senior author’s full institutional base is incomplete, the omission can flatten the collaborative structure behind a study that likely depends on multidisciplinary expertise.
The corrected affiliations now place Julian C. Hong within both the Helen Diller Family Comprehensive Cancer Center and Weill Cancer Hub West, strengthening the visible connection between the article and the broader UCSF- and Stanford-linked oncology ecosystem. For readers, that clarification helps situate the work inside a research environment that is plausibly aligned with advanced cancer trial methodology and computational clinical support.
No patient-level consequences follow from this specific correction, and no clinical safety signal is being reported here. The notice is narrower: it restores accuracy to the publication record for a paper at the interface of oncology and machine learning. In a discipline where trust rests on exacting documentation, even a single missing affiliation warrants correction.
The journal has now updated the article to reflect the complete institutional listing for the author in question, closing the loop on a metadata error while leaving the science unchanged.